Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
European Journal of Preventive Cardiology|May 22, 2026
Efficacy and Safety of Oral PCSK9 Inhibitors: Insights from a Meta-analysis of RCTSElena Olmastroni, Sining Xie, Federica Galimberti, et al.
Pharmacy (Basel, Switzerland)|February 25, 2025
Operational Definitions of Polypharmacy and Their Association with All-Cause Hospitalization Risk: A Conceptual Framework Using Administrative DatabasesStefano Scotti, Lorenza Scotti, Federica Galimberti, et al.
Nature Reviews. Cardiology|April 9, 2021
Global epidemiology of dyslipidaemiasAngela Pirillo, Manuela Casula, Elena Olmastroni, et al.
European Journal of Internal Medicine|February 1, 2025
Lipoprotein(a) and prothrombotic effects: Evidence from a genetic association studyElena Olmastroni, Julius L Katzmann, Federica Galimberti, et al.
Pharmacological Reviews|June 5, 2026
Are we underestimating the benefits of lipid-lowering therapies?Angela Pirillo, Manuela Casula, Elena Olmastroni, et al.
Atherosclerosis. Supplements|February 16, 2021
How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemiaMarta Gazzotti, Manuela Casula, Elena Olmastroni, et al.
Pharmacological Research|July 8, 2020
Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trialsManuela Casula, Elena Olmastroni, Marta Gazzotti, et al.
Atherosclerosis|July 6, 2025
Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trialsSining Xie, Federica Galimberti, Elena Olmastroni, et al.
Nutrients|May 28, 2022
Adherence to the Mediterranean Diet: Impact of Geographical Location of the ObservationsElisa Mattavelli, Elena Olmastroni, Daniela Bonofiglio, et al.
Pharmacological Research|March 31, 2019
Cardiovascular events with PCSK9 inhibitors: an updated meta-analysis of randomised controlled trialsManuela Casula, Elena Olmastroni, Mezio T Boccalari, et al.
Pageof 6